Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia

Etan Orgel(Children's Hospital of Los Angeles), Steven D. Mittelman(Children's Hospital of Los Angeles), Cecilia Fu(University of Southern California), Jonathan Tucci(Children's Hospital of Los Angeles), Richard Sposto(Children's Hospital of Los Angeles), Jemily Malvar(University of Southern California), Hisham Abdel‐Azim(University of Southern California), David R. Freyer(University of Southern California), Waseem Alhushki(Children's Heart Center Nevada)

Blood

October 27, 2014

10.1182/blood-2014-08-595389

Cited by 108

Related Papers

Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group

|Journal of Clinical Oncology|2012|433

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

|Blood|2006|431

Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale

|Journal of Clinical Oncology|2012|375

Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study

|The Lancet Oncology|2020|370

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

|Blood|2006|362